SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
XOMA. Bull or Bear?
An SI Board Since July 1996
Posts SubjectMarks Bans Symbol
17367 72 0 XOMA
Emcee:  Olu Emuleomo Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
15967Tell me what you did with the evidence and I will talk to Spielberg. With hundraknahow-8/13/2002
15966..."best bang for the buck trial"...Gw did it again, I love it, it is Cacaito-8/13/2002
15965Cacaito, have you ever considered that one large drug/biotech company might try aknahow-8/13/2002
15964You know that your beloved FDA does not demand any particular trial. DNA/Xoma haknahow-8/13/2002
15963Gw, you are the best Amevive promoter, Mullen must love you, thanks to your sheCacaito-8/13/2002
15962"" According to you, a third party created a clinical problem foaknahow-8/13/2002
15961Man, you are so wrong about Biogen, despite their alleged performance the stock Cacaito-8/13/2002
15960Just the fact, just the facts. I hold BGEN in awe. I have never seen a better aknahow-8/13/2002
15959I get it spin master, no matter how many questions about cRaptiva, your answer iCacaito-8/13/2002
15958New patent, issued today 13 Aug. SUMMARY OF THE INVENTION The present inventiaknahow-8/13/2002
15957You don't seem to get it. first Amevive worked with only about 21% anytime aknahow-8/12/2002
15956Any further information about the Raptiva "weaning" trial??? Mr Gw, NCacaito-8/12/2002
15955Cacaito, in other post you have been direct about what you call flare up after aaknahow-8/11/2002
15954Attach a misile warhead to rBpi21 ...(or 22 for that matter) and send it to the Cacaito-8/11/2002
15953Robert glad your back. There is a Robert S. and he at times insist on finding aaknahow-8/11/2002
15952the significance is baxter and xoma have yet to harness and exploit its power. wRobert K.-8/10/2002
15951Hi Bob. What is the significance of this???? xoma.comBluegreen-8/9/2002
15950"hanging in there"... with the rope around the neck !!! The "recCacaito-8/9/2002
15949Well.........here I am. Here are some notes and stuff. First, I am not up to speRobert K.-8/9/2002
1594870 days in May. In the recent past Xoma has done quite well. One can sense a qaknahow-8/9/2002
15947Xoma gets 25% of the gross profits in the U.S. It pays 12.5% of the development aknahow-8/8/2002
15946Nice partner for Europe... Why did not Roche exercise its first right to any DnCacaito-8/8/2002
15945SOURCE: Serono S.A. Serono and Genentech Announce International Marketing Agreeaknahow-8/8/2002
15944Cacaito, your friend Harmon posted this on another thread. You know what I thinaknahow-8/7/2002
15943An investor presentation per month through November. Bluegreen, do you know of aknahow-8/7/2002
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News